Silverback Therapeutics Inc (NASDAQ:SBTX)

5.10
Delayed Data
As of 3:59pm ET
 -0.38 / -6.93%
Today’s Change
2.80
Today|||52-Week Range
11.19
-23.42%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Silverback Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a -1.96% decrease from the last price of 5.10.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in Silverback Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$0.00
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 36.36%
 
 
 
 
 
 
Growthannually 25.00%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.